US FDA approves Bayer drug for specific type of lung cancer

The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...
CURE

FDA Approves Hyrnuo in Some with Locally Advanced/Metastatic NSCLC

The FDA has approved Hyrnuo for some with locally advanced or metastatic non-squamous non–small cell lung cancer with ...
MedPage Today on MSN

New FDA-Approved Option for HER2-Mutated Lung Cancer

The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).
MedPage Today on MSN

Triglyceride-Lowering Drug Gets FDA Nod for Rare Genetic Disorder

The small interfering RNA (siRNA) therapy, designed to reduce triglyceride levels by suppressing production of apolipoprotein ...

EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing option in all approved indications provides greater dosing ...
Targeted Oncology

FDA Grants Daratumumab and Hyaluronidase-fihj Traditional Approval for Newly Diagnosed Light Chain Amyloidosis

The ANDROMEDA trial showed improved MOD-PFS and OS with daratumumab and hyaluronidase plus VCd compared to VCd alone in light ...

SMX Brings Identity to American Plastics as FDA-Compliant Molecular Marking Turns rPET Into a Certified Commodity

NEW YORK, NY / ACCESS Newswire / November 14, 2025 / For decades, plastics have moved through the world without an identity. They were manufactured, used, discarded, shredded, melted, and remade, but ...
Targeted Oncology

FDA Approves Sevabertinib in HER2-Mutated Nonsquamous NSCLC

The FDA has granted an accelerated approval to sevabertinib (Hyrnuo) for the treatment of adult patients with previously treated locally advanced or metastatic, nonsquamous non–small cell lung cancer ...

Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Receives Second, Larger 5kg Psilocybin Shipment via USA Controlled Substances Import Permit

Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based ...

Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

The top-line data from the first cohort demonstrate a favorable safety profile, with no serious adverse events reported and the treatment generally well-tolerated across all participants. Additionally ...

US FDA approves Bayer's drug for a type of lung cancer

The U.S. Food and Drug Administration on Wednesday said it has approved Bayer's drug for patients with a type of lung cancer ...